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Abstract
Cigarette smoking is associated with increased inflammation and defective antibacterial
responses in the airways. Interestingly, vitamin D has been shown to suppress inflammation
and to improve antibacterial defense. However, it is currently unknown whether vitamin D
may modulate inflammation and antibacterial defects in human cigarette smoke (CS)-
exposed airways. To explore these unresolved issues, alveolar macrophages obtained
from non-smoking and smoking subjects as well as human cigarette smoke extract (CSE)-
treated THP-1 macrophages were stimulated with 1,25-dihydroxyvitamin D (1,25(OH)2D) to
address inflammatory and antibacterial responses. Although basal levels of inflammatory
cytokines and chemokines did not differ between non-smoking and smoking subjects, 1,25
(OH)2D did reduce levels of IL-6, TNF-α and MCP-1 in alveolar macrophages in response
to LPS/IFN-γ, although not statistically significant for TNF-α and IL-6 in smokers. CSE did
not significantly alter vitamin D metabolism (expression levels of CYP24A1 or CYP27B1) in
THP-1 macrophages. Furthermore, stimulation with 1,25(OH)2D reduced mRNA expression
levels and/or protein levels of IL-8, TNF-α and MCP-1 in CSE-treated THP-1 macrophages.
1,25(OH)2D did not improve defects in phagocytosis of E. coli bacteria or the oxidative burst
response in CSE-treated THP-1 macrophages or alveolar macrophages from smokers.
However, 1,25(OH)2D significantly enhanced mRNA expression and/or protein levels of the
antimicrobial peptide cathelicidin in alveolar macrophages and THP-1 macrophages, inde-
pendently of CS exposure. In conclusion, our results provide the first evidence that vitamin
D could be a new strategy for attenuating airway inflammation and improving antibacterial
defense in CS-exposed airways.
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Introduction
In recent years, it has become apparent that the active form of vitamin D, 1,25-dihydroxyvita-
min D (1,25(OH)2D), is not only important for calcium and bone homeostasis, but also exerts
important innate immunomodulatory functions [1]. 1,25(OH)2D has been shown to inhibit
the production of inflammatory cytokines and chemokines in vitro in response to various
inflammatory and/or infectious stimuli [2–5]. In addition to these anti-inflammatory actions,
1,25(OH)2D may improve antibacterial defense by stimulating phagocytosis [6–8] as well as by
enhancing the production of reactive oxygen species (oxidative burst) [9] and antimicrobial
peptides (including cathelicidin) [10,11], which both are important for the efficient killing of
bacteria.
Cigarette smoking is a global epidemic and a major risk factor for several life-threatening
diseases, including chronic obstructive pulmonary disease (COPD). Alveolar macrophages are
crucial in initiating the inflammatory response to cigarette smoke (CS) by releasing inflamma-
tory cytokines and chemokines, such as IL-8 and MCP-1 [12]. This then recruits additional
inflammatory cells, including monocytes and neutrophils, to the lungs, which amplifies the
inflammatory response. Alveolar macrophages are furthermore important resident phagocytes
in the lung, contributing to the clearance of infections [13]. However, CS has been shown to
impair antibacterial defense, including the phagocytic uptake of bacteria by macrophages, as
demonstrated by in vitro as well as in vivo animal research [14–19].
Given the anti-inflammatory and antibacterial functions of 1,25(OH)2D, it is tempting to
speculate that 1,25(OH)2D could counteract these effects of CS. However, few studies have sug-
gested that CS could affect vitamin D metabolism by increasing CYP24A1 (24-hydroxylase,
catabolizing enzyme that degrades 1,25(OH)2D) [20] or decreasing CYP27B1 (1α-hydroxylase,
activating enzyme leading to formation of 1,25(OH)2D) [21]. As CYP24A1, CYP27B1, but also
the vitamin D receptor (VDR) are expressed locally within the lungs [22], such as in alveolar
macrophages, these effects of CS on vitamin D metabolism could potentially limit immuno-
modulatory effects of vitamin D within the respiratory tract. As such, it is still unclear whether
1,25(OH)2D modulates pulmonary inflammatory responses and/or antibacterial defects in CS-
exposed airways. As macrophages are major players in inflammatory and antibacterial
responses in the airways, we investigated the effect of 1,25(OH)2D on i) ex vivo responses of
alveolar macrophages from smoking subjects (compared to non-smoking subjects), and ii)
THP-1 macrophages exposed to cigarette smoke extract (CSE).
Materials and Methods
Experiments involving human samples were approved by the Ethical Committee of University
Hospital UZ Leuven (S54148) and all subjects gave informed, written consent.
Bronchoalveolar lavage (BAL) of non-smoking and smoking subjects
Non-smoking (n = 10) and smoking (n = 11) subjects, undergoing bronchoscopy for diagnostic
reasons, were recruited. Non-smokers were defined as subjects with a normal lung function
who never smoked or stopped smoking for more than 5 years, while smokers were defined as
subjects with a normal lung function who were current smokers at the moment of BAL sam-
pling (34±5 pack-years). Normal lung function was defined as forced expiratory volume in 1
second (FEV1)%> 80% and Tiffeneau-index (FEV1 over forced vital capacity (FVC; FEV1/
FVC)> 0.7. Non-smokers and smokers were matched for age (non-smoker: 66.4±3.14 years;
smokers: 59.8±2.29 years; p = 0.0982) and gender (non-smoker: 60% male; smoker: 64% male;
p = 0.8639). To reduce bias from bacterial colonization and chronic inflammation, COPD
patients were a priori excluded. As a consequence, none of the subjects were taking oral or
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inhaled corticosteroids or showed any signs of acute respiratory infection at the moment of
BAL sampling. BAL was performed according to standard procedures [23]. BAL consisted of
four aliquots of 50 ml sterile saline instilled in the right middle lobe or lingula. BAL samples
were filtered and cells were resuspended in culture medium (RPMI 1640 medium-Glutamax
supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin, 100 μg/ml streptomycin,
and 2.5 mg/ml fungizone). Alveolar macrophages were isolated by incubating BAL cells for 2
hours at 37°C to allow adherence of macrophages. Afterwards, non-adherent cells were
removed by repeatedly replacing the medium. Alveolar macrophages were stimulated for 48h
with 10-8M 1,25(OH)2D (Sigma-Aldrich, St-Louis, MO, USA). The dose and exposure time of
1,25(OH)2D were based upon literature [24,25]. In certain conditions, alveolar macrophages
were additionally stimulated for 24h with a combination of LPS (1 μg/ml) and IFN-γ, (100 IU/
ml), a strong inflammatory stimulus [25]. To correct for the different number of alveolar mac-
rophages in each sample, all samples were diluted to 2x106 cells/ml with culture medium.
THP-1 macrophages
As the number of BAL samples obtained from non-smoking and smoking subjects was limited,
additional experiments were performed on the THP-1 monocytic cell line, differentiated into
macrophages, which represent a useful model to study alveolar macrophage responses [26].
Differentiation and stimulation of THP-1 monocytic cell line. The THP-1 human acute
monocytic leukemia cell line (ATCC, Manassas, VA, USA) was cultured in RPMI medium sup-
plemented with 10% fetal calf serum (FCS), 100 U/ml penicillin, 100 μg/ml streptomycin, 2
mM L-glutamine and 2.5 μg/ml fungizone at 37°C (5% CO2). To induce differentiation into
adherent macrophages, THP-1 cells were stimulated overnight with phorbol 12-myristate
13-acetate (PMA; Sigma-Aldrich) (30 ng/ml) and were allowed to rest for two additional days.
THP-1 macrophages were stimulated for 16h with CSE, followed by an additional 24h stimula-
tion with 10-8M 1,25(OH)2D (1,25(OH)2D post-treatment). For certain experiments, THP-1
macrophages were also pre-treated with 1,25(OH)2D (Methods in S1 File).
Preparation of CSE. CSE was generated by bubbling the smoke of 1 cigarette (3R4F
research cigarettes, Kentucky Tobacco Research and Development Center, University of Ken-
tucky) through 10 ml of culture medium. The pH was adjusted to 7.4 and CSE was filtered
through a 0.2 mm pore filter (Millipore). The resulting solution was considered 100% CSE.
CSE was freshly prepared and used within 30 minutes. To ensure standardization between dif-
ferent preparations of CSE, the absorbance was adjusted to OD 0.4 at 340 nm.
Cytotoxicity. Cytotoxicity due to CSE exposure was evaluated using the MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Cells were incubated for
3h with MTT dissolved in HBSS (0.5 mg/ml). The precipitated formazan product was then dis-
solved in DMSO and absorbance was recorded at a 550 nm wavelength and a reference wave-
length of 655 nm. Results are expressed as a percentage of the control values (Figures A and B
in S1 File).
Inflammatory response
mRNA and protein levels of inflammatory cytokines and chemokines. Protein levels of
IL-8, TNF-α, MCP-1 and IL-6 were measured in cell-free supernatants of alveolar macrophage
and THP-1 macrophage cultures using the Mesoscale Discovery (MSD) technology, according
to the manufacturer’s instructions. mRNA expression levels of IL-8, TNF-α, MCP-1 and IL-6
in THP-1 macrophages were determined with real-time PCR. Therefore, a constant amount of
1 μg of RNA was reverse transcribed with Superscript III reverse transcriptase (Invitrogen, Life
Technologies, Lennik, Belgium). The quantitative PCR amplification reaction was performed
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using a thermal cycler (Eco Real-Time PCR system, Illumina). Primer sequences are shown in
Table 1. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as housekeeping
gene and data were normalized using the comparative cycle threshold (Ct) method.
Antibacterial response
Phagocytosis and oxidative burst. The phagocytic and oxidative burst capacity was
assessed by flow cytometry using an adaptation of the commercial kit BURSTTEST (Orpegen
Pharma, Heidelberg, Germany). Briefly, THP-1 macrophages or cells from human BAL sam-
ples were incubated for 2 hours at 37°C with pH-rodoRed-labeled E. coli bacteria (pHrodoTM
Red E. coli Bioparticles1 Phagocytosis kit for flow cytometry, Invitrogen), previously opso-
nized with E. coli Bioparticles1 opsonizing reagent (Invitrogen). Afterwards, the fluorogenic
substrate rhodamine was added for an additional 20 minutes at 37°C. Samples were acquired
on a Gallios flow cytometer (Beckman Coulter, Brea, CA, USA) and analyzed with the Kaluza
software (Beckman Coulter). For human BAL samples, alveolar macrophages were identified
on flow cytometry by staining BAL cells with fluorochrome-labeled monoclonal antibodies
against CD11b, CD33 and HLA-DR (eBioscience) for 20 minutes at 4°C.
mRNA expression levels and protein levels of cathelicidin. mRNA expression levels of
cathelicidin in THP-1 macrophages were determined with real-time PCR, as described above.
Primer sequences are shown in Table 1. Levels of cathelicidin in cell-free supernatants of alveo-
lar macrophage and THP-1 macrophage cultures were measured with the human LL-37 ELISA
kit (Hycult biotech), according to the manufacturer’s instructions.
mRNA expression levels of proteins in the vitamin D pathway
mRNA expression levels of VDR, CYP27B1 and CYP24A1 in THP-1 macrophages were deter-
mined with real-time PCR, as described above. Primer sequences are shown in Table 1.
Table 1. Primers used for quantitative PCR analysis.
Target Sequence
GAPDH • 5’-TGGTATCGTGGAAGGACTCA-3' (FW)
• 5’-CCAGTAGAGGCAGGGATGAT-3' (RV)
IL-8 • 5’-CATCTTCACTGATTCTTGGATACC-3’ (FW)
• 5’-TGTCTGGACCCCAAGGAA-3’ (RV)
TNF-α • 5’-TCAGCTTGAGGGTTTGCTAC-3’ (FW)
• 5’-TGCACTTTGGAGTGATCGG-3’ (RV)
MCP-1 • 5’-GCCTCTGCACTGAGATCTTC-3’ (FW)
• 5’-AGCAGCCACCTTCATTCC-3’ (RV)
IL-6 • 5’-TTCTGTGCCTGCAGCTTC-3’ (FW)
• 5’-GCAGATGAGTACAAAAGTCCTGA-3’(RV)
Cathelicidin • 5’-GGGCTCCTTTGACATCAGTT-3’ (FW)
• 5’-AGCAGGGCAAATCTCTTGTT -3’ (RV)
VDR • 5’-GATTGGAGAAGCTGGACGAG-3’ (FW)
• 5’-GTTCGTGTGAATGATGGTGGA-3’ (RV)
CYP27B1 • 5’-CGCACTGTCCCAAAGCTG-3’ (FW)
• 5’-CGGAGCTTGGCAGACATC-3’ (RV)
CYP24A1 • 5’-GTGACCATCATCCTCCCAAA-3’ (FW)
• 5’-AGTATCTGCCTCGTGTTGTATG-3’ (RV)
FW: forward primer; RV: reverse primer
doi:10.1371/journal.pone.0160482.t001
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Statistical analysis
Data were analyzed using SAS software version 9.3 and are presented as mean±SEM. Differ-
ences between groups were analyzed using a two-way ANOVA with a Tukey-Kramer post-hoc
test for multiple group comparison. A mixed model was applied to account for independent
experiments (THP-1 macrophages) or individual patient samples (human alveolar macro-
phages). Differences were considered significant when p-values were less than 0.05.
Results
1,25(OH)2D inhibits ex vivo inflammatory responses of alveolar
macrophages from both non-smokers and smokers
We aimed to investigate whether 1,25(OH)2D influences ex vivo inflammatory and/or antibac-
terial responses of alveolar macrophages from smoking subjects. Therefore, BAL samples were
obtained from age- and gender-matched non-smoking and smoking subjects. No differences
were observed for basal levels of IL-8, TNF-α, MCP-1 and IL-6 produced by alveolar macro-
phages from non-smokers or smokers. Treatment with 1,25(OH)2D did not alter these basal
levels released by alveolar macrophages from non-smoking or smoking subjects (data not
shown). However, when alveolar macrophages were additionally stimulated for 24h with a
combination of LPS and IFN-γ, a strong inflammatory stimulus, 1,25(OH)2D significantly
reduced levels of TNF-α, MCP-1 and IL-6 in alveolar macrophages from non-smoking subjects
in response to LPS/IFN-γ (Fig 1). Similar trends were observed for alveolar macrophages from
smoking subjects, although not statistically significant for levels of TNF-α and IL-6 (Fig 1). No
significant differences were observed for levels of IL-8 released by alveolar macrophages from
both non-smokers and smokers (Fig 1).
1,25(OH)2D does not affect ex vivo phagocytic or oxidative burst
responses, but enhances release of cathelicidin from alveolar
macrophages from both non-smoking and smoking subjects
The phagocytic uptake of E. coli bacteria was significantly decreased in alveolar macrophages
from smokers compared to non-smokers (Fig 2A). The production of reactive oxygen species
(oxidative burst) by alveolar macrophages was also decreased in smokers compared to non-
smokers, although not reaching statistical significance (Fig 2B). Stimulation with 1,25(OH)2D
did not significantly alter phagocytic or oxidative burst responses of alveolar macrophages
from non-smoking and smoking individuals. In contrast, stimulation with 1,25(OH)2D signifi-
cantly enhanced the release of the antimicrobial peptide cathelicidin from alveolar macro-
phages to the same extent in both non-smokers and smokers (Fig 2C).
1,25(OH)2D inhibits the inflammatory response in CSE-treated THP-1
macrophages
As the number of BAL samples obtained from non-smoking or smoking subjects and the num-
ber of cells recovered from these samples was limited, a THP-1 macrophage cell line model for
alveolar macrophages was used. To investigate whether 1,25(OH)2D may affect inflammatory
responses in a context of CS exposure, THP-1 macrophages were exposed to 10 or 25% CSE as
these CSE concentrations did not induce cytotoxicity (Figure A in S1 File). The effect of 1,25
(OH)2D treatment on mRNA expression and protein levels of inflammatory cytokines and
chemokines was assessed. Post-treatment with 1,25(OH)2D significantly reduced mRNA and/
or protein levels of IL-8, TNF-α and MCP-1 compared to treatment with 10% CSE alone (Fig
3). Treatment with 1,25(OH)2D did not significantly alter protein levels of IL-8 induced by
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CSE (Fig 3). mRNA and protein levels of IL-6 could not be detected in all conditions. Experi-
ments with 25% CSE showed similar results (data not shown). When pretreating THP-1 cells
with 1,25(OH)2D prior to 10% CSE exposure, a similar reduction of inflammatory cytokines
was also obtained (Fig 4).
Fig 1. Effect of 1,25(OH)2D on the ex vivo inflammatory response of alveolar macrophages from non-smoking and smoking subjects.
Alveolar macrophages from non-smokers (n = 5) or smokers (n = 5) were stimulated for 48h with 10 nM 1,25(OH)2D or vehicle, followed by an
additional stimulation for 24h with LPS/IFN-γ. Levels of (A) IL-8, (B) TNF-α, (C) MCP-1 and (D) IL-6 were measured in supernatants of alveolar
macrophage cultures. mean±SEM. *p<0.05, ***p<0.001.
doi:10.1371/journal.pone.0160482.g001
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1,25(OH)2D does not improve phagocytic or oxidative burst defects of
THP-1 macrophages induced by CSE, but upregulates mRNA and
protein levels of cathelicidin
The phagocytic uptake of E. coli bacteria or oxidative burst by THP-1 macrophages was signifi-
cantly decreased after exposure to 25% CSE (Fig 5A and 5B), but not 10% CSE (data not shown).
However, 1,25(OH)2D did not improve phagocytosis or oxidative burst by THP-1 macrophages
exposed to 25% CSE or vehicle (Fig 5A and 5B). On the other hand, 1,25(OH)2D significantly
increased mRNA and protein levels of cathelicidin in THP-1macrophages, which was not affected
by the exposure to 10% CSE (Fig 4C) or 25% CSE (data not shown). All experiments on THP-1
macrophages were performed with 10% and 25% of CSE. As the results on cytokine release and
concomitant suppression by 1,25(OH)2D were not different for both concentrations, we reported
only the results obtained with 10% of CSE. However, to obtain a significant reduction of phagocy-
tosis capacity 25% CSE was needed, without being toxic to these cells (Figure A in S1 File).
Exposure to CSE does not alter expression levels of the activating or
catabolizing enzyme of 1,25(OH)2D in THP-1 macrophages
Finally, we wanted to investigate whether CSE may influence the expression of important pro-
teins in the vitamin D pathway (CYP24A1, CYP27B1 or VDR) and in this way could limit
anti-inflammatory or antibacterial actions of 1,25(OH)2D within CS-exposed airways. Stimula-
tion with 1,25(OH)2D did not affect mRNA expression levels of VDR or CYP27B1, but signifi-
cantly upregulated expression levels of CYP24A1, a known target for 1,25(OH)2D, in THP-1
macrophages (Fig 6). Treatment with 10% CSE did not significantly alter expression levels of
CYP27B1 or CYP24A1 in THP-1 macrophages, although VDR expression levels were slightly,
but significantly increased following treatment with 10% CSE (Fig 6). Experiments with 25%
CSE showed similar results (data not shown).
Discussion
In vitro research has demonstrated important antibacterial functions as well as anti-inflamma-
tory effects of 1,25(OH)2D in response to different inflammatory stimuli. However, currently,
Fig 2. Effect of 1,25(OH)2D on ex vivo antibacterial response of alveolar macrophages from non-smoking and smoking subjects. Alveolar
macrophages from non-smokers or smokers were stimulated for 48h with 10 nM 1,25(OH)2D or vehicle. (A) Phagocytosis and (B) oxidative burst
by alveolar macrophages from non-smokers (n = 7) and smokers (n = 11) following bacterial challenge. Graphs show the percentage of alveolar
macrophages that have internalized E. coli bacteria (A) or have produced reactive oxygen species (B). (C) Cathelicidin levels were measured in
supernatants of alveolar macrophage cultures from non-smokers (n = 5) and smokers (n = 5). mean±SEM. *p<0.05, **p<0.01.
doi:10.1371/journal.pone.0160482.g002
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it is not known whether vitamin D could influence inflammation and antibacterial defects in
CS-exposed airways. As alveolar macrophages play a major role in innate immune processes
within the respiratory system [12,13], we investigated in the present study whether 1,25
(OH)2D may affect ex vivo responses of alveolar macrophages from smoking individuals.
Unexpectedly, no differences were observed in baseline release of inflammatory mediators
between alveolar macrophages from smokers and non-smokers, which may correlate with the
low-grade baseline inflammation observed in the enrolled subjects, in whom COPD and other
inflammatory pulmonary disease was excluded. To compare effects of 1,25(OH)2D on inflam-
matory responses between smoking and non-smoking subjects, alveolar macrophages were
additionally stimulated with a strong inflammatory stimulus, a combination of LPS and IFN-γ,
[25]. Interestingly, 1,25(OH)2D inhibited the release of pro-inflammatory cytokines (TNF-α,
MCP-1 and IL-6) by alveolar macrophages from both non-smokers and smokers in response
to LPS/IFN-γ stimulation. These results extend the idea that the anti-inflammatory potential of
vitamin D in healthy individuals may also persist in smokers. However, due to small sample
size, caution should be taken with general conclusions regarding our ex vivo data. In particular,
the use of different concentrations of 1,25(OH)2D exposure but also different exposure times
may possibly lead to slightly different results. To overcome the problem of a limited number of
available macrophages per sample, we used PMA-stimulated THP-1 cells, which represent a
useful model to study alveolar macrophage responses and which were previously shown to
maintain a normal vitamin D metabolism [26,27]. In THP-1 macrophages, treatment with 1,25
(OH)2D significantly reduced mRNA and/or protein levels of IL-8, TNF-α and MCP-1 in
response to CSE. These results are in line with previous reports demonstrating the downregula-
tion of pro-inflammatory cytokine production by 1,25(OH)2D in innate immune cells in
response to inflammatory signals other than CS. In monocytes/macrophages, 1,25(OH)2D
reduced the production of TNF-α and/or IL-6 in response to LPS by inhibiting NF-κB and p38
MAPK activity [2,5]. Moreover, Hansdottir and colleagues demonstrated that vitamin D atten-
uated the induction of IL-8 mRNA by viral mimetic poly(I:C) in airway epithelial cells [4]. Sim-
ilarly, Golden and colleagues found that 1,25(OH)2D reduced IL-8 release by human bronchial
epithelial cells and human peripheral blood monocytes induced by organic dust [3]. By lower-
ing levels of cytokines and chemokines in response to CS, 1,25(OH)2D may indirectly reduce
infiltration of inflammatory cells, including macrophages and neutrophils, into the airways
and in this way downregulate the airway inflammatory response. Interestingly, in an animal
model of acute lung injury, it has already been shown that intratracheal or peroral administra-
tion of 1,25(OH)2D inhibits the recruitment of neutrophils after LPS inhalation [28].
CS has been shown to impair antibacterial defense. In vitro, exposure to CSE reduced the
phagocytic capacity of both macrophages and neutrophils [14,19]. Furthermore, we have previ-
ously shown that CS exposure of mice results in reduced ex vivo phagocytic and oxidative burst
responses of alveolar macrophages in the BAL fluid [29]. In this study, we confirm that CS
impairs antibacterial defense, as the phagocytic uptake of E. coli bacteria was significantly
decreased in alveolar macrophages obtained from smoking subjects compared to non-smoking
subjects. Similar trends were observed for the oxidative burst capacity of alveolar macrophages,
although not statistically significant. Consistent with these results, both the phagocytic and oxi-
dative burst capacity of THP-1 macrophages was reduced by exposure to CSE. These defects in
Fig 3. Effect of 1,25(OH)2D on the inflammatory response in CSE-treated THP-1 macrophages. THP-1
macrophages were stimulated for 16h with 10% CSE or vehicle, followed by an additional stimulation for 24h with 10 nM
1,25(OH)2D or vehicle. mRNA and protein levels of (A) IL-8, (B) TNF-α and (C) MCP-1 were determined in cell lysates
and culture supernatants, respectively. Independent experiments were performed in triplicate. mean±SEM. *p<0.05,
**p<0.01, ****p<0.0001.
doi:10.1371/journal.pone.0160482.g003
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the antibacterial functionality of macrophages may explain why cigarette smokers are more
susceptible to respiratory infections [30]. However, in both human alveolar macrophages or
THP-1 macrophages, 1,25(OH)2D did not significantly alter the phagocytic or oxidative burst
capacity. In contrast to these findings, previous in vitro studies have demonstrated that 1,25
(OH)2D can improve the phagocytic capacity as well as the oxidative burst functions of mono-
cytes [6–9]. These effects of 1,25(OH)2D on monocyte antibacterial functions are potentially
explained by the prodifferentiating effects of 1,25(OH)2D on monocytes, which adopt a more
mature phenotype [6,22]. In addition, some of these studies have been performed with different
cells (including P388D1 and phagocytic cells obtained from normal human peripheral blood).
Although the dose used in our study (10-8M) was in the range that has been shown to have an
effect on phagocytic capacity and oxidative burst, the different outcome may be explained by
the use of different cell types. The effect of CSE on phagocytosis and oxidative burst was only
clear when we used a CSE of 25% instead of the 10% reported for all other experiments with
THP-1 cells. This generates the interesting hypothesis that the decrease in phagocytosis and
oxidative burst only present at high levels of CSE could correlate with increased bronchial
infections in heavy vs light smokers. However, to our current knowledge there are no reports
in human of impaired macrophage function caused by cigarette smoke and its subsequent risk
for infection. Although 1,25(OH)2D did not affect phagocytic or oxidative burst antibacterial
functions, 1,25(OH)2D treatment significantly increased levels of the antimicrobial peptide
cathelicidin released by alveolar macrophages from both smoking and non-smoking individu-
als. Consistently, we demonstrated that 1,25(OH)2D upregulates mRNA and protein levels of
cathelicidin in THP-1 macrophages, independent of CSE exposure. Upregulation of cathelici-
din by 1,25(OH)2D has been demonstrated in several cell types, including macrophages and
neutrophils, and has shown to be crucial in the intracellular killing ofMycobacterium tubercu-
losis [10,11]. Moreover, cathelicidin exerts bactericidal activity to a broad spectrum of bacteria,
including both Gram-positive and Gram-negative bacteria by disrupting bacterial membranes.
Therefore, our results from both alveolar macrophages and THP-1 macrophages suggest that
1,25(OH)2D could improve antibacterial defense, also in a CS environment by upregulating
cathelicidin, however, without affecting bacterial uptake or oxygen-dependent intracellular
killing.
There are a few limitations of our study that need to be mentioned. Firstly, antibacterial
defense was only assessed by measuring phagocytosis and oxidative burst following challenge
with E. coli bacteria and mRNA expression and/or protein levels of cathelicidin. Although our
data provide the first evidence of the antibacterial potential of 1,25(OH)2D in CS-exposed mac-
rophages, it still needs to be explored whether the upregulation of cathelicidin also results in
the effective clearance of more relevant bacterial species causing respiratory tract infections,
such as nontypeable Haemophilus influenzae and Streptococcus pneumoniae, in cultures of CS-
exposed cells using bactericidal assays. Secondly, the number of BAL samples and the number
of cells recovered from these samples was limited. Therefore, not all outcomes could be
assessed in cultures of human alveolar macrophages (e.g. mRNA expression levels of inflam-
matory mediators or proteins in the vitamin D pathway). Moreover, because of large variation
between different human BAL samples, statistical significance was not always reached. Finally,
we used CSE of which the physiological relevance in terms of tobacco smoke exposure is hard
Fig 4. Effect of pre-treatment with 1,25(OH)2D on the inflammatory response of CSE-treated THP-1
macrophages. THP-1 macrophages were stimulated for 24h with 10 nM 1,25(OH)2D or vehicle, followed by an
additional 16h stimulation with 10% CSE or vehicle. mRNA and protein levels of (A) IL-8, (B) TNF-α and (C) MCP-1 were
determined in cell lysates and culture supernatants, respectively. Independent experiments were performed in triplicate.
mean±SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.
doi:10.1371/journal.pone.0160482.g004
Cigarette Smoke, Vitamin D and Macrophage Responses
PLOS ONE | DOI:10.1371/journal.pone.0160482 August 11, 2016 11 / 16
to interpret. Although we standardized the extracts to 10 or 25% concentrations based upon
optical density, it is also hard to compare them with concentrations used in other studies.
Fig 5. Effect of 1,25(OH)2D on antibacterial response in CSE-treated THP-1 macrophages. THP-1 macrophages were stimulated
for 16h with 10% or 25% CSE or vehicle, followed by an additional stimulation for 24h with 10 nM 1,25(OH)2D or vehicle. (A)
Phagocytosis and (B) oxidative burst by THP-1 macrophages following bacterial challenge. Graphs show the percentage of alveolar
macrophages that have internalized E. coli bacteria (A) or have produced reactive oxygen species (B). (C) mRNA and protein levels of
cathelicidin were determined in cell lysates and culture supernatants, respectively. Independent experiments were performed in
triplicate. mean±SEM. **p<0.01, ***p<0.001, ****p<0.0001.
doi:10.1371/journal.pone.0160482.g005
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A few studies have suggested that CS exposure may interfere with vitamin D metabolism
and in this way with immunomodulatory functions of vitamin D within the respiratory tract.
In this context, Mulligan et al. demonstrated that CSE downregulated CYP27B1 expression in
control human sinonasal epithelial cells, leading to less conversion of 25OHD to 1,25(OH)2D
[21]. Moreover, benzopyrene, a constituent of CS, was shown to enhance the 1,25(OH)2D-
dependent induction of CYP24A1 in THP-1 cells [20]. In contrast, we did not find significant
effects of CSE on expression levels of important proteins in the vitamin D pathway (VDR,
CYP27B1 and CYP24A1) in THP-1 macrophages. In addition, preliminary data show no sig-
nificant difference in CYP27B1 or CYP24A1 expression between the alveolar macrophages of
non-smokers and smokers (data not shown). Although these findings should be confirmed in
primary cells like respiratory epithelial cells from smoking subjects, our results suggest that
vitamin D may provide a new strategy for attenuating inflammation and improving antibacte-
rial defense in CS-exposed airways. Although our study did not specifically address the inflam-
mation related to COPD, it is tempting to discuss our findings in the context of COPD, where
CS exposure and vitamin D deficiency are strongly associated [22,31]. Moreover, different
studies have demonstrated an accelerated decline of lung function (forced expiratory volume
in 1 second, FEV1) and increased likelihood for COPD onset in smokers with vitamin D defi-
ciency [32,33]. At this stage, there are no data showing that optimization of vitamin D status
may prevent COPD onset, but two randomized placebo-controlled intervention trials have
shown benefit of vitamin D supplementation in COPD patients with vitamin D deficiency with
regard to exacerbations [34,35]. Therefore, our in vitro research may indirectly suggest that
vitamin D supplementation, through the attenuation of macrophage-driven inflammation and
the upregulation of cathelicidin levels, may reduce the risk of respiratory infections and COPD
in smokers.
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